A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction (Q41159551)
Jump to navigation
Jump to search
scientific article published on 14 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction |
scientific article published on 14 July 2012 |
Statements
1 reference
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction (English)
1 reference
1 reference
1 reference
1 reference
Ramon Salazar
1 reference
Paul Roepman
1 reference
Mireille Snel
1 reference
Sun Tian
1 reference
Iris Simon
1 reference
Laura van't Veer
1 reference
1 reference
Identifiers
1 reference